Avanos Medical, Inc.
US ˙ NYSE ˙ US05350V1061

SecurityAVNS / Avanos Medical, Inc.
InstitutionFifth Third Bancorp
Latest Disclosed Ownership11,722 shares
Latest Disclosed Value $ 164,225
Fifth Third Bancorp reports 5,180.18% increase in ownership of AVNS / Avanos Medical, Inc.

On May 1, 2026 - Fifth Third Bancorp filed a 13F-HR form disclosing ownership of 11,722 shares of Avanos Medical, Inc. (US:AVNS) valued at $164,225 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 222 shares of Avanos Medical, Inc.. This represents a change in shares of 5,180.18% during the quarter. The current value of the position is $293,050 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F AVANOS MED COM 05350V106 11,722 11,500 5,180.18 164 8,100.00 0.0003
2026-02-02 2025-12-31 13F AVANOS MED COM 05350V106 222 -2 -0.89 2 0.00 0.0000
2025-11-07 2025-09-30 13F AVANOS MED COM 05350V106 224 -45 -16.73 3 -33.33 0.0000
2025-07-15 2025-06-30 13F AVANOS MED COM 05350V106 269 114 73.55 3 50.00 0.0000
2025-04-15 2025-03-31 13F AVANOS MED COM 05350V106 155 -175 -53.03 2 -60.00 0.0000
2025-01-21 2024-12-31 13F AVANOS MED COM 05350V106 330 67 25.48 5 -16.67 0.0000
2024-10-17 2024-09-30 13F AVANOS MED COM 05350V106 263 43 19.55 6 50.00 0.0000
2024-07-22 2024-06-30 13F AVANOS MED COM 05350V106 220 90 69.23 4 100.00 0.0000
2024-04-23 2024-03-31 13F AVANOS MED COM 05350V106 130 -19 -12.75 3 -33.33 0.0000
2024-01-19 2023-12-31 13F AVANOS MED COM 05350V106 149 -236 -61.30 3 -57.14 0.0000
2023-10-31 2023-09-30 13F AVANOS MED COM 05350V106 385 211 121.26 8 75.00 0.0000
2023-07-26 2023-06-30 13F AVANOS MED COM 05350V106 174 -74 -29.84 4 -42.86 0.0000
2023-04-24 2023-03-31 13F AVANOS MED COM 05350V106 248 56 29.17 7 40.00 0.0000
2023-01-25 2022-12-31 13F AVANOS MED COM 05350V106 192 19 10.98 5 25.00 0.0000
2022-10-25 2022-09-30 13F AVANOS MED COM 05350V106 173 173 4 0.0000
2022-08-04 2022-06-30 13F AVANOS MED COM 05350V106 0 -301 -100.00 0 -100.00
2022-04-19 2022-03-31 13F AVANOS MED COM 05350V106 301 -140 -31.75 10 -33.33 0.0000
2022-02-01 2021-12-31 13F AVANOS MED COM 05350V106 441 348 374.19 15 400.00 0.0001
2021-10-15 2021-09-30 13F AVANOS MED COM 05350V106 93 61 190.62 3 200.00 0.0000
2021-08-06 2021-06-30 13F AVANOS MED COM 05350V106 32 -265 -89.23 1 -92.31 0.0000
2021-05-07 2021-03-31 13F AVANOS MED COM 05350V106 297 167 128.46 13 116.67 0.0001
2021-02-16 2020-12-31 13F AVANOS MED COM 05350V106 130 35 36.84 6 100.00 0.0000
2020-11-09 2020-09-30 13F AVANOS MED COM 05350V106 95 -206 -68.44 3 -66.67 0.0000
2020-08-05 2020-06-30 13F AVANOS MED COM 05350V106 301 -3 -0.99 9 12.50 0.0001
2020-05-05 2020-03-31 13F AVANOS MED COM 05350V106 304 9 3.05 8 -20.00 0.0001
2020-02-14 2019-12-31 13F AVANOS MED COM 05350V106 295 95 47.50 10 42.86 0.0001
2019-11-14 2019-09-30 13F AVANOS MED COM 05350V106 200 0 0.00 7 -22.22 0.0000
2019-08-07 2019-06-30 13F AVANOS MED COM 05350V106 200 0 0.00 9 0.00 0.0001
2019-05-14 2019-03-31 13F AVANOS MED COM 05350V106 200 -33 -14.16 9 -10.00 0.0001
2019-02-14 2018-12-31 13F AVANOS MED COM 05350V106 233 21 9.91 10 -33.33 0.0001
2018-11-14 2018-09-30 13F AVANOS MED COM 05350V106 212 -36 -14.52 15 7.14 0.0001
2018-08-14 2018-06-30 13F HALYARD HEALTH COM 40650V100 248 -303 -54.99 14 -44.00 0.0001
2018-05-15 2018-03-31 13F HALYARD HEALTH COM 40650V100 551 -47 -7.86 25 -10.71 0.0002
2018-02-14 2017-12-31 13F HALYARD HEALTH COM 40650V100 598 10 1.70 28 7.69 0.0002
2017-11-14 2017-09-30 13F HALYARD HEALTH COM 40650V100 588 31 5.57 26 18.18 0.0002
2017-08-11 2017-06-30 13F HALYARD HEALTH COM 40650V100 557 0 0.00 22 4.76 0.0002
2017-05-12 2017-03-31 13F HALYARD HEALTH COM 40650V100 557 -62 -10.02 21 -8.70 0.0002
2017-02-13 2016-12-31 13F/A-1 HALYARD HEALTH COM 40650V100 619 -168 -21.35 23 -14.81 0.0002
2017-02-09 2016-12-31 13F HALYARD HEALTH COM 40650V100 787 0 27 0.0002
2016-11-10 2016-09-30 13F HALYARD HEALTH COM 40650V100 787 -345 -30.48 27 -27.03 0.0002
2016-08-11 2016-06-30 13F HALYARD HEALTH COM 40650V100 1,132 -1,890 -62.54 37 -57.47 0.0003
2016-05-13 2016-03-31 13F HALYARD HEALTH COM 40650V100 3,022 900 42.41 87 22.54 0.0008
2016-02-16 2015-12-31 13F HALYARD HEALTH COM 40650V100 2,122 463 27.91 71 51.06 0.0006
2015-11-13 2015-09-30 13F HALYARD HEALTH COM 40650V100 1,659 -1,140 -40.73 47 -58.41 0.0004
2015-08-14 2015-06-30 13F HALYARD HEALTH COM 40650V100 2,799 4 0.14 113 -18.12 0.0010
2015-05-14 2015-03-31 13F HALYARD HEALTH COM 40650V100 2,795 -2,737 -49.48 138 -45.24 0.0012
2015-02-13 2014-12-31 13F HALYARD HEALTH COM 40650V100 5,532 5,532 252 0.0022
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.